RNA vaccines saved lives during the COVID-19 pandemic, but older people had less of an immune response to the vaccines than ...

Regeneron (REGN) and Sanofi (SNY) announced that the FDA has accepted for review the resubmission of the supplemental Biologics License ...

Development of the coronavirus disease 2019 (COVID-19) vaccine has been key to countering the pandemic caused by severe acute ...

Evidence shows that the vaccines used in Canada are very effective at preventing severe illness, hospitalization and death from COVID-19. It's important to receive a primary series and a booster dose ...

Kennedy, known as a persistent critic of vaccine safety and a booster of conspiracy theories, said it is a possibility he ...

The agreement will last five years. Read also: Flu vaccinations and Covid-19 booster shots now available in France: who's eligible and how to get them Some over 80s could also pay €60 (fully ...

The EMA has kicked off a rolling review of a COVID-19 vaccine from Sanofi and GlaxoSmithKline, which started a 35,000-patient phase 3 trial in May. The vaccine – now dubbed Vidprevtyn – is ...

GSK plc GSK reported third-quarter 2024 core earnings of $1.27 per American depositary share (ADS), which beat the Zacks Consensus Estimate of $1.16. Core earnings declined 1% year over year on a ...

and with it comes a new round of COVID-19 booster shots. Expecting an increase in COVID-19 cases ahead of the holidays, the Biden Administration relaunched the free at-home COVID-19 test kits the ...

(RTTNews) - Sanofi announced that Beyfortus (nirsevimab) will be broadly available for babies born in Ontario, Quebec, Nunavut, Northwest Territories, and the Yukon this fall. The administration ...

He went on to explain that a misconfigured component didn’t have the right “ramp up time for bringing up spin pressure” on the booster. “We were one second away from that tripping and ...